Ralf Kuriyel
Chief Tech/Sci/R&D Officer en REPLIGEN CORPORATION .
Fortuna: 3 M $ al 31/03/2024
Perfil
En la actualidad, Ralf Kuriyel es Vicepresidente Senior de Investigación y Desarrollo en Repligen Corp. Anteriormente fue Vicepresidente de Investigación y Desarrollo de Pall Life Sciences y Vicepresidente de I+D de aplicaciones de campo en Pall Corp. El Sr. Kuriyel se licenció y se graduó en el Instituto Politécnico Rensselaer.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
REPLIGEN CORPORATION
0.03% | 18/03/2024 | 17 719 ( 0.03% ) | 3 M $ | 31/03/2024 |
Cargos activos de Ralf Kuriyel
| Empresas | Cargo | Inicio |
|---|---|---|
| REPLIGEN CORPORATION | Chief Tech/Sci/R&D Officer | 18/10/2016 |
Antiguos cargos conocidos de Ralf Kuriyel.
| Empresas | Cargo | Fin |
|---|---|---|
| PALL CORPORATION | Corporate Officer/Principal | 01/10/2016 |
Cytiva US LLC
 Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Chief Tech/Sci/R&D Officer | 01/10/2016 |
Formación de Ralf Kuriyel.
| Tufts University | Doctorate Degree |
| Rensselaer Polytechnic Institute | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| Empresas privadas | 2 |
|---|---|
Pall Corp.
 Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Health Technology |
- Bolsa de valores
- Insiders
- Ralf Kuriyel
